Randomized Trial Comparing the Effects of Ticagrelor Versus Clopidogrel on Myocardial Perfusion in Patients With Coronary Artery Disease

BACKGROUND: Ticagrelor is a P2Y(12) receptor inhibitor used in acute coronary syndromes to reduce platelet activity and to decrease thrombus formation. Ticagrelor is associated with a reduction in mortality incremental to that observed with clopidogrel, potentially related to its non–antiplatelet ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelletier‐Galarneau, Matthieu, Hunter, Chad R. R. N., Ascah, Kathryn J., Beanlands, Rob S. B., Dwivedi, Girish, deKemp, Robert A., Chow, Benjamin J. W., Ruddy, Terrence D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524115/
https://www.ncbi.nlm.nih.gov/pubmed/28465300
http://dx.doi.org/10.1161/JAHA.117.005894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524115/
https://www.ncbi.nlm.nih.gov/pubmed/28465300
http://dx.doi.org/10.1161/JAHA.117.005894

Ejemplares similares